Rudd Co d/b/a Styre Wealth’s Pfizer PFE Stock Holding History

Rudd Co d/b/a Styre Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.68M	Buy	+57,185	New	+$1.52M	1.64%	21

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Rudd Co d/b/a Styre Wealth's PFE Position: Q3 2026 in Review

Rudd Co d/b/a Styre Wealth opened a new position in Pfizer (PFE) in Q3 2026: 57,185 shares worth $1.68M. The stake represents 1.64% of the portfolio and ranks #21 among its holdings.

1,268 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Rudd Co d/b/a Styre Wealth held 57,185 shares of Pfizer worth $1.68M as of Q3 2026.
Pfizer was a new Rudd Co d/b/a Styre Wealth position in Q3 2026.
Pfizer made up 1.64% of Rudd Co d/b/a Styre Wealth's portfolio in Q3 2026, its #21 holding.
1,268 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Rudd Co d/b/a Styre Wealth's 13F filing for Q3 2026, filed 29 Oct 2026.